ChemoCentryx
CCXI
#3635
Rank
HK$29.15 B
Marketcap
HK$405.33
Share price
0.00%
Change (1 day)
33.93%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: HK$29.15 Billion

On November 25, 2022 ChemoCentryx had a market cap of HK$29.15 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022HK$29.21 B46.94%
2021HK$19.88 B-40.15%
2020HK$33.22 B79.06%
2019HK$18.55 B328.74%
2018HK$4.32 B90.89%
2017HK$2.26 B-17.36%
2016HK$2.74 B-1.11%
2015HK$2.77 B20.52%
2014HK$2.30 B19.53%
2013HK$1.92 B-37.54%
2012HK$3.08 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
HK$188.05 B 545.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$2.953 T 10,031.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$759.78 B 2,506.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
HK$877.04 B 2,908.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$4.107 T 13,989.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.387 T 4,658.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.136 T 3,800.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$284.07 B 874.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
HK$2.119 T 7,170.02%๐Ÿ‡บ๐Ÿ‡ธ USA